Trump Nominates General LaNeve to Lead the Army Permanently
President Donald Trump has nominated Gen. Chris LaNeve, acting Army chief of staff since April, to lead the service permanently, subject to Senate confirmation.
News that stays with you.
President Donald Trump has nominated Gen. Chris LaNeve, acting Army chief of staff since April, to lead the service permanently, subject to Senate confirmation.
France worst unrest in years caused estimated damage above 1 billion euros, with nearly 2,400 arrests in one weekend, and that bill is the context for the Senate protesters pay law.
Reports say Gulf allies have been briefed to prepare for a short, intense campaign against Iran as soon as November 4, while President Trump has not made a final decision and diplomacy continues.
France's protest numbers remain disputed, with competing counts of 410,000 and 800,000 for a single day, as student leaders vow to demonstrate on Saturday and November 5.
The Oleshky ceasefire window runs until November 1, and with two days left the question is whether aid can reach residents before the deadline lapses.
Top stories, once a day. No spam.
Air India has resumed nonstop flights to New York and Newark from Delhi and Mumbai, cutting travel time by up to five hours after curbs eased on Sunday.
Jensen Huang has agreed to brief House lawmakers before Thanksgiving, with the date still under negotiation, as Congress presses its probe of the Nvidia chip pipeline.
Any team that buys application records faces the same first question: can this data be trusted, and can that trust be shown, not just…
The VA is piloting CLEAR1 identity verification on VA.gov, offering selfie sign-in and in-person pods at six medical centres nationwide.
Patrick Mahomes threw five touchdown passes as Kansas City rolled to a 35 to 13 win at Atlanta, in a performance that reminded the league what the Chiefs can do when their quarterback is on form.
Universal's The Odyssey has crossed $1.767 billion worldwide, cementing its place among the highest-grossing films of all time.
The FDA approved Tecentriq plus chemotherapy for stage III dMMR colon cancer after the ATOMIC trial showed a 50% cut in recurrence risk.
Cygnus XL departed the ISS after six months and is set for a controlled destructive re-entry into Earth's atmosphere today.
Answers come from this site’s published pages. Anything else goes to the team.